Use of a standardized web-based tool (WBT) for evaluation of aromatase inhibitor (AI) related bone loss in breast cancer patients (BCP)

20754 Background: ASCO guidelines recommend AI adjuvant therapy in postmenopausal hormone receptor positive BCP. AI treated BCP have a higher rate of osteoporosis (OP); timely diagnosis and treatme...